IBDEI2L1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41214,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,41214,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,41215,0)
 ;;=E11.41^^152^2030^6
 ;;^UTILITY(U,$J,358.3,41215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41215,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,41215,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,41215,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,41216,0)
 ;;=E11.42^^152^2030^13
 ;;^UTILITY(U,$J,358.3,41216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41216,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41216,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,41216,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,41217,0)
 ;;=E11.43^^152^2030^2
 ;;^UTILITY(U,$J,358.3,41217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41217,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41217,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,41217,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,41218,0)
 ;;=E11.44^^152^2030^1
 ;;^UTILITY(U,$J,358.3,41218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41218,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,41218,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,41218,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,41219,0)
 ;;=E11.49^^152^2030^8
 ;;^UTILITY(U,$J,358.3,41219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41219,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,41219,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,41219,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,41220,0)
 ;;=E11.59^^152^2030^25
 ;;^UTILITY(U,$J,358.3,41220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41220,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,41220,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,41220,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,41221,0)
 ;;=E11.610^^152^2030^9
 ;;^UTILITY(U,$J,358.3,41221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41221,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,41221,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,41221,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,41222,0)
 ;;=E11.618^^152^2030^26
 ;;^UTILITY(U,$J,358.3,41222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41222,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,41222,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,41222,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,41223,0)
 ;;=E11.621^^152^2030^16
 ;;^UTILITY(U,$J,358.3,41223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41223,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,41223,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,41223,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,41224,0)
 ;;=E11.622^^152^2030^31
 ;;^UTILITY(U,$J,358.3,41224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41224,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,41224,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,41224,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,41225,0)
 ;;=E11.628^^152^2030^30
 ;;^UTILITY(U,$J,358.3,41225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41225,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,41225,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,41225,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,41226,0)
 ;;=E11.630^^152^2030^33
 ;;^UTILITY(U,$J,358.3,41226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41226,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,41226,1,4,0)
 ;;=4^E11.630
